Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Johnson and Johnson
Harvard Business School
Dow
Mallinckrodt

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Cellobiose

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Cellobiose: Patents, clinical trial progress, indications

Cellobiose is an investigational drug.

There have been 5 clinical trials for Cellobiose. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2012.

The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, and Chronic Disease. The leading clinical trial sponsors are GlaxoSmithKline, Federico II University, and [disabled in preview].

There are two US patents protecting this investigational drug and twenty-five international patents.

Recent Clinical Trials for Cellobiose
TitleSponsorPhase
A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in PediaFederico II UniversityPhase 4
A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 DaysGlaxoSmithKlinePhase 2
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.GlaxoSmithKlinePhase 2

See all Cellobiose clinical trials

Clinical Trial Summary for Cellobiose

Top disease conditions for Cellobiose
Top clinical trial sponsors for Cellobiose

See all Cellobiose clinical trials

US Patents for Cellobiose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cellobiose   Start Trial Polypeptides with permease activity DSM IP ASSETS B.V. (Heerlen, NL)   Start Trial
Cellobiose   Start Trial 5-hydroxymethylfurfural production using a multi-fluorinated alcohol compound Klaus-Dieter Vorlop (Braunschweig, DE) Ulf Pruesse (Braunschweig, DE)   Start Trial
Cellobiose   Start Trial Polypeptides having beta-xylosidase activity and polynucleotides encoding same Novozymes, Inc. (Davis, CA)   Start Trial
Cellobiose   Start Trial Vasopressin formulations for use in treatment of hypotension Par Pharmaceutical, Inc. (Chestnut Ridge, NY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Cellobiose

Drugname Country Document Number Estimated Expiration Related US Patent
Cellobiose Argentina 096533 2033-06-05   Start Trial
Cellobiose Argentina 096534 2033-06-05   Start Trial
Cellobiose Argentina 096537 2033-06-05   Start Trial
Cellobiose China 105263955 2033-06-05   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Colorcon
Merck
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.